Acadia Pharmaceuticals (ACAD) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -123.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.93% |
| Dec 31, 2025 | -137.86% |
| Sep 30, 2025 | 12.99% |
| Jun 30, 2025 | 6.36% |
| Mar 31, 2025 | 26.82% |
| Dec 31, 2024 | 339.28% |
| Sep 30, 2024 | 154.77% |
| Jun 30, 2024 | 902.21% |
| Mar 31, 2024 | 128.39% |
| Dec 31, 2023 | 175.86% |
| Sep 30, 2023 | -87.18% |
| Jun 30, 2023 | 109.02% |
| Mar 31, 2023 | 52.59% |
| Dec 31, 2022 | -150.84% |
| Sep 30, 2022 | -101.73% |
| Jun 30, 2022 | 23.01% |
| Mar 31, 2022 | -69.26% |
| Dec 31, 2021 | -43.52% |
| Sep 30, 2021 | 82.19% |
| Jun 30, 2021 | 0.68% |
| Mar 31, 2021 | 25.41% |
| Dec 31, 2020 | 384.44% |
| Sep 30, 2020 | -89.12% |
| Jun 30, 2020 | 22.91% |
| Mar 31, 2020 | -2.15% |
| Dec 31, 2019 | -143.74% |
| Sep 30, 2019 | 25.87% |
| Jun 30, 2019 | 10.91% |
| Mar 31, 2019 | -59.86% |
| Dec 31, 2018 | 284.18% |
| Sep 30, 2018 | 6.66% |
| Jun 30, 2018 | 5.82% |
| Mar 31, 2018 | 38.21% |
| Dec 31, 2017 | 10.51% |
| Sep 30, 2017 | 9.33% |
| Jun 30, 2017 | 5.40% |
| Mar 31, 2017 | -76.52% |
| Dec 31, 2016 | -223.69% |
| Sep 30, 2016 | -85.65% |
| Jun 30, 2016 | -82.10% |
| Mar 31, 2016 | -23.94% |
| Dec 31, 2015 | 90.31% |
| Sep 30, 2015 | -56.03% |
| Jun 30, 2015 | -81.82% |
| Mar 31, 2015 | -125.82% |
| Dec 31, 2014 | 151.19% |
| Sep 30, 2014 | -131.19% |
| Jun 30, 2014 | -137.23% |
| Mar 31, 2014 | -191.34% |
| Dec 31, 2013 | 294.03% |
| Sep 30, 2013 | -349.15% |
| Jun 30, 2013 | -68.67% |
| Mar 31, 2013 | 1.08% |
| Dec 31, 2012 | -28.32% |
| Sep 30, 2012 | 52.74% |
| Jun 30, 2012 | 17.54% |
| Mar 31, 2012 | -6.31% |
| Dec 31, 2011 | -118.24% |
| Sep 30, 2011 | -20.06% |